Daniel Grosslight
Stock Analyst at Citigroup
(1.10)
# 3,839
Out of 5,090 analysts
111
Total ratings
33.33%
Success rate
-15.28%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Buy | $12 → $9.5 | $3.94 | +141.12% | 5 | Nov 21, 2025 | |
| HCAT Health Catalyst | Maintains: Neutral | $3.5 → $3.25 | $2.59 | +25.48% | 11 | Nov 11, 2025 | |
| CTEV Claritev | Maintains: Buy | $74 → $80 | $33.95 | +135.64% | 3 | Nov 10, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $165 → $190 | $198.83 | -4.44% | 10 | Oct 31, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $47 → $49 | $34.35 | +42.65% | 2 | Oct 31, 2025 | |
| TDOC Teladoc Health | Maintains: Neutral | $9.5 → $11 | $7.59 | +38.34% | 12 | Oct 21, 2025 | |
| MCK McKesson | Maintains: Buy | $820 → $860 | $808.62 | +6.35% | 8 | Sep 24, 2025 | |
| OMI Owens & Minor | Maintains: Buy | $11 → $7 | $2.59 | +170.27% | 7 | Aug 12, 2025 | |
| AGL agilon health | Downgrades: Neutral | $3 → $1 | $0.65 | +53.33% | 6 | Aug 6, 2025 | |
| HIMS Hims & Hers Health | Maintains: Sell | $25 → $30 | $39.20 | -23.47% | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $6.25 | $2.71 | +130.63% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $35 | $20.29 | +72.50% | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $23.84 | +4.87% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $3.78 | +164.90% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $13.07 | -38.79% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $1.39 | -10.07% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $3.08 | +13.64% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $9.42 | +38.00% | 1 | Dec 11, 2019 |
Evolent Health
Nov 21, 2025
Maintains: Buy
Price Target: $12 → $9.5
Current: $3.94
Upside: +141.12%
Health Catalyst
Nov 11, 2025
Maintains: Neutral
Price Target: $3.5 → $3.25
Current: $2.59
Upside: +25.48%
Claritev
Nov 10, 2025
Maintains: Buy
Price Target: $74 → $80
Current: $33.95
Upside: +135.64%
Cardinal Health
Oct 31, 2025
Maintains: Neutral
Price Target: $165 → $190
Current: $198.83
Upside: -4.44%
Waystar Holding
Oct 31, 2025
Maintains: Buy
Price Target: $47 → $49
Current: $34.35
Upside: +42.65%
Teladoc Health
Oct 21, 2025
Maintains: Neutral
Price Target: $9.5 → $11
Current: $7.59
Upside: +38.34%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $820 → $860
Current: $808.62
Upside: +6.35%
Owens & Minor
Aug 12, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $2.59
Upside: +170.27%
agilon health
Aug 6, 2025
Downgrades: Neutral
Price Target: $3 → $1
Current: $0.65
Upside: +53.33%
Hims & Hers Health
May 6, 2025
Maintains: Sell
Price Target: $25 → $30
Current: $39.20
Upside: -23.47%
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $2.71
Upside: +130.63%
Jan 10, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $20.29
Upside: +72.50%
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $23.84
Upside: +4.87%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $3.78
Upside: +164.90%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $13.07
Upside: -38.79%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $1.39
Upside: -10.07%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $3.08
Upside: +13.64%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $9.42
Upside: +38.00%